Clindamycin intravenous dose

1.2 to 1.8 g of clindamycin per day in 3 or 4 equal doses intravenously or intramuscularly. Serious infections: 2.4 to 2.7 g of clindamycin per day in 2, 3 or 4 equal doses intravenously or intramuscularly. Severe infections: The dose may be increased, although the maximum recommended dose is 2.7 g of clindamycin per day.

1.2 to 1.8 g of clindamycin per day in 3 or 4 equal doses intravenously or intramuscularly. Serious infections: 2.4 to 2.7 g of clindamycin per day in 2, 3 or 4 equal doses intravenously or intramuscularly. Severe infections: The dose may be increased, although the maximum recommended dose is 2.7 g of clindamycin per day.

1.2 to 1.8 g of clindamycin per day in 3 or 4 equal doses intravenously or intramuscularly. Serious infections: 2.4 to 2.7 g of clindamycin per day in 2, 3 or 4 equal doses intravenously or intramuscularly. Severe infections: The dose may be increased, although the maximum recommended dose is 2.7 g of clindamycin per day.

Low-dose clindamycin therapy is an alternative suppressive regimen. KEY b) For concomitant cellulitis, use intravenous clindamycin, nafcillin

Active Clindamycin After Dosing with Clindamycin Phosphate. Dosage Significant mortality was observed in mice at an intravenous dose of 855 mg/kg and in.

Clindamycin phosphate, Clindamycin hydrochloride. Dose and Indications. Infection due to susceptible organisms. Intravenous, Oral. Infectious Disease

dosages of drugs like clindamycin represents a critical Safety and Pharmacokinetics of Multiple-Dose Intravenous Oral Clindamycin

IV(2). In the Australian context safety of intravenous clindamycin in preterm and term infants. The median clindamycin dose was 5.1 mg/kg/dose

Clindamycin phosphate IV in intravenous infusion in a dose of 600 to 900 mg every 6 hours or Clindamycin phosphate IV in intravenous infusion in a dose of 900